BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 15106798)

  • 1. Relationship between ambulatory blood pressure and follow-up clinic blood pressure in elderly patients with systolic hypertension.
    Fagard RH; Staessen JA; Thijs L; Bulpitt CJ; Clement D; de Leeuw PW; Jääskivi M; Mancia G; O'Brien E; Palatini P; Tuomilehto J; Webster J;
    J Hypertens; 2004 Jan; 22(1):81-7. PubMed ID: 15106798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population.
    Pringle E; Phillips C; Thijs L; Davidson C; Staessen JA; de Leeuw PW; Jaaskivi M; Nachev C; Parati G; O'Brien ET; Tuomilehto J; Webster J; Bulpitt CJ; Fagard RH;
    J Hypertens; 2003 Dec; 21(12):2251-7. PubMed ID: 14654744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
    Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
    JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Task force IV: Clinical use of ambulatory blood pressure monitoring. Participants of the 1999 Consensus Conference on Ambulatory Blood Pressure Monitoring.
    Staessen JA; Beilin L; Parati G; Waeber B; White W
    Blood Press Monit; 1999 Dec; 4(6):319-31. PubMed ID: 10602536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential follow-up clinic and ambulatory blood pressure evaluation in a low risk population of white-coat hypertensive patients and in normotensives.
    Polónia JJ; Gama GM; Silva JA; Amaral C; Martins LR; Bertoquini SE
    Blood Press Monit; 2005 Apr; 10(2):57-64. PubMed ID: 15812251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy.
    Dolan E; Stanton AV; Thom S; Caulfield M; Atkins N; McInnes G; Collier D; Dicker P; O'Brien E;
    J Hypertens; 2009 Apr; 27(4):876-85. PubMed ID: 19516185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension.
    Fagard RH; Celis H; Thijs L; Staessen JA; Clement DL; De Buyzere ML; De Bacquer DA
    Hypertension; 2008 Jan; 51(1):55-61. PubMed ID: 18039980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the 'white-coat' effect. Syst-Eur investigators.
    Parati G; Omboni S; Staessen J; Thijs L; Fagard R; Ulian L; Mancia G
    J Hypertens; 1998 Jan; 16(1):23-9. PubMed ID: 9533413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Pressure Monitoring. Task force III: Target-organ damage, morbidity and mortality.
    Verdecchia P; Clement D; Fagard R; Palatini P; Parati G
    Blood Press Monit; 1999 Dec; 4(6):303-17. PubMed ID: 10602535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the efficacy and duration of action of candesartan cilexetil and losartan as assessed by clinic and ambulatory blood pressure after a missed dose, in truly hypertensive patients: a placebo-controlled, forced titration study. Candesartan/Losartan study investigators.
    Lacourcière Y; Asmar R
    Am J Hypertens; 1999 Dec; 12(12 Pt 1-2):1181-7. PubMed ID: 10619580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory pulse pressure as predictor of outcome in older patients with systolic hypertension.
    Staessen JA; Thijs L; O'Brien ET; Bulpitt CJ; de Leeuw PW; Fagard RH; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J; Safar ME;
    Am J Hypertens; 2002 Oct; 15(10 Pt 1):835-43. PubMed ID: 12372669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of blood pressure level and need for antihypertensive medication: 10 years of follow-up.
    Jokiniitty JM; Majahalme SK; Kähönen MA; Tuomisto MT; Turjanmaa VM
    J Hypertens; 2001 Jul; 19(7):1193-201. PubMed ID: 11446708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive efficacy of lercanidipine at 2.5, 5 and 10 mg in mild to moderate essential hypertensives assessed by clinic and ambulatory blood pressure measurements. Multicenter Study Investigators.
    Omboni S; Zanchetti A
    J Hypertens; 1998 Dec; 16(12 Pt 1):1831-8. PubMed ID: 9869018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive effects of amlodipine and hydrochlorothiazide in elderly patients with ambulatory hypertension.
    Lacourcière Y; Poirier L; Lefebvre J; Archambault F; Cléroux J; Boileau G
    Am J Hypertens; 1995 Dec; 8(12 Pt 1):1154-9. PubMed ID: 8998248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension.
    Palatini P; Thijs L; Staessen JA; Fagard RH; Bulpitt CJ; Clement DL; de Leeuw PW; Jaaskivi M; Leonetti G; Nachev C; O'Brien ET; Parati G; Rodicio JL; Roman E; Sarti C; Tuomilehto J;
    Arch Intern Med; 2002 Nov; 162(20):2313-21. PubMed ID: 12418945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference between office and ambulatory blood pressure and response to antihypertensive treatment.
    Parati G; Omboni S; Mancia G
    J Hypertens; 1996 Jun; 14(6):791-7. PubMed ID: 8793703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Task Force II: blood pressure measurement and cardiovascular outcome.
    Staessen JA; Asmar R; De Buyzere M; Imai Y; Parati G; Shimada K; Stergiou G; Redón J; Verdecchia P;
    Blood Press Monit; 2001 Dec; 6(6):355-70. PubMed ID: 12055415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.